BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 25213465)

  • 1. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages.
    Jang SE; Jeong JJ; Hyam SR; Han MJ; Kim DH
    J Agric Food Chem; 2014 Oct; 62(40):9711-21. PubMed ID: 25213465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
    Lee IA; Hyam SR; Jang SE; Han MJ; Kim DH
    J Agric Food Chem; 2012 Sep; 60(38):9595-602. PubMed ID: 22849695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways.
    Jeong JJ; Jang SE; Hyam SR; Han MJ; Kim DH
    Eur J Pharmacol; 2014 Oct; 740():652-61. PubMed ID: 24972244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages.
    Lee IA; Park YJ; Joh EH; Kim DH
    J Agric Food Chem; 2011 Dec; 59(24):13165-72. PubMed ID: 22060784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice.
    Hyam SR; Jang SE; Jeong JJ; Joh EH; Han MJ; Kim DH
    Int Immunopharmacol; 2013 Feb; 15(2):433-41. PubMed ID: 23352442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages.
    Hyam SR; Lee IA; Gu W; Kim KA; Jeong JJ; Jang SE; Han MJ; Kim DH
    Eur J Pharmacol; 2013 May; 708(1-3):21-9. PubMed ID: 23375938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways.
    Joh EH; Gu W; Kim DH
    Biochem Pharmacol; 2012 Aug; 84(3):331-40. PubMed ID: 22564908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Sitosterol attenuates high-fat diet-induced intestinal inflammation in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 in the NF-κB pathway.
    Kim KA; Lee IA; Gu W; Hyam SR; Kim DH
    Mol Nutr Food Res; 2014 May; 58(5):963-72. PubMed ID: 24402767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.
    Jang SE; Hyam SR; Jeong JJ; Han MJ; Kim DH
    Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
    Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH
    Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.
    Lee SY; Jeong JJ; Eun SH; Kim DH
    Eur J Pharmacol; 2015 Sep; 762():333-43. PubMed ID: 26054809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance.
    Kang GD; Kim DH
    J Ethnopharmacol; 2016 Aug; 189():175-85. PubMed ID: 27224242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
    Chun J; Lee C; Hwang SW; Im JP; Kim JS
    Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages.
    Jang SE; Han MJ; Kim SY; Kim DH
    Int Immunopharmacol; 2014 Jul; 21(1):186-92. PubMed ID: 24815859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation.
    Lee IA; Hyun YJ; Kim DH
    Eur J Pharmacol; 2010 Dec; 648(1-3):162-70. PubMed ID: 20828550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages.
    Jang SE; Hyam SR; Han MJ; Kim SY; Lee BG; Kim DH
    J Appl Microbiol; 2013 Sep; 115(3):888-96. PubMed ID: 23742179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.
    Joh EH; Kim DH
    Br J Pharmacol; 2011 Apr; 162(8):1731-42. PubMed ID: 21198552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Methoxylonchocarpin attenuates inflammation by inhibiting lipopolysaccharide binding to Toll-like receptor of macrophages and M1 macrophage polarization.
    Jang HM; Kang GD; Van Le TK; Lim SM; Jang DS; Kim DH
    Int Immunopharmacol; 2017 Apr; 45():90-97. PubMed ID: 28189973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soyasaponin I attenuates TNBS-Induced colitis in mice by inhibiting NF-κB pathway.
    Lee IA; Park YJ; Yeo HK; Han MJ; Kim DH
    J Agric Food Chem; 2010 Oct; 58(20):10929-34. PubMed ID: 20923188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.